[PDF][PDF] Clinical validation study results of a multivariate proteomic serum based assay for disease activity assessments in multiple sclerosis
CONCLUSIONS• To clinically validate a blood based multiplex proteomic DA test for
associations with gadolinium enhancing (Gd+) lesions, New and Enlarging T2 lesions (N/E
T2) and Active/Stable status (combination of Gd+, N/E T2 and clinical relapse status) using
serum samples obtained from 4 sites: Brigham and Women's Hospital (BWH), University of
Massachusetts (UMASS), American University of Beirut (AUB) and the Rocky Mountain
Multiple Sclerosis Clinic (RMMSC).• The current standard of care to evaluate disease activity …
associations with gadolinium enhancing (Gd+) lesions, New and Enlarging T2 lesions (N/E
T2) and Active/Stable status (combination of Gd+, N/E T2 and clinical relapse status) using
serum samples obtained from 4 sites: Brigham and Women's Hospital (BWH), University of
Massachusetts (UMASS), American University of Beirut (AUB) and the Rocky Mountain
Multiple Sclerosis Clinic (RMMSC).• The current standard of care to evaluate disease activity …